Anti-CD20 monoclonal antibodies: reviewing a revolution
2018 · Human Vaccines & Immunotherapeutics · 121 citations
https://doi.org/10.1080/21645515.2018.1508624
J
Joshua Casan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
435
Citations
10
h-index
10
i10-index
Joshua Casan is an academic researcher from The University of Melbourne. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CRISPR and Genetic Engineering & CAR-T cell therapy research. The author has an h-index of 10, co-authored 39 publications.
ORCID: 0000-0002-4322-8561Papers by this author
worksEfficient mRNA delivery to resting T cells to reverse HIV latency
2025 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-025-60001-2
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
2024 · The Lancet Haematology · 9 citations
https://doi.org/10.1016/s2352-3026(24)00317-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat